Exelixis
EXEL
#1644
Rank
NZ$16.60 B
Marketcap
$59.33
Share price
-2.49%
Change (1 day)
49.69%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $84.79 NZD on 2000-07-26

Lowest end of day price: $2.22 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$57.85-2.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
$85.50-3.03%๐Ÿ‡ซ๐Ÿ‡ท France
$133.52-5.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$86.88-6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$484.50-3.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$256.00-1.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$37.17-4.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.01-4.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.83 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA